21
Participants
Start Date
January 31, 2007
Primary Completion Date
March 31, 2007
Study Completion Date
February 29, 2008
Ketorolac tromethamine
30 mg of intranasal ketorolac tromethamine (one 100 µL spray into each nostril of a 15%, pH 7.2 solution)
Oxymetazoline hydrochloride
Single intranasal dose of oxymetazoline hydrochloride (Afrazine®) (3 sprays of a 0.05% solution into each nostril) followed 30 minutes later by 30 mg of intranasal ketorolac tromethamine (one 100 µL spray into each nostril of a 15%, pH 7.2 solution)
ICON Development Solutions, Manchester
Lead Sponsor
Egalet Ltd
INDUSTRY